Department of Obstetrics and Gynaecology, Maastricht University Medical Centre+, Maastricht, The Netherlands.
GROW School for Oncology and Reproduction, Maastricht University, Universiteitssingel, Maastricht, The Netherlands.
Reprod Fertil. 2023 Dec 13;4(4). doi: 10.1530/RAF-23-0065. Print 2023 Oct 1.
Sex steroids are converted to bioactive metabolites and vice versa by endometrial steroid-metabolising enzymes. Studies indicate that alterations in this metabolism might affect endometrial receptivity. This pilot study determined whether the endometrial formation and inactivation of 17β-oestradiol differed between the supposedly embryo-receptive endometrium and non-receptive endometrium of women undergoing IVF/intracytoplasmic sperm injection (ICSI). Endometrial biopsies were obtained from IVF/ICSI patients 5-8 days after ovulation in a natural cycle, prior to their second IVF/ICSI cycle with fresh embryo transfer (ET). Endometrial biopsies from patients who achieved clinical pregnancy after fresh ET (n = 15) were compared with endometrial biopsies from patients that did not conceive after fresh ET (n = 15). Formation of 17β-oestradiol (oxidative 17β-hydroxysteroid dehydrogenases (HSDs)), oestrone (reductive HSD17Bs) and inhibition of HSD17B1 activity were determined by high-performance liquid chromatography. The endometrial transcriptome was profiled using RNA sequencing followed by principal component analysis and differentially expressed gene analysis. The false discovery rate-adjusted P < 0.05 and log fold change >0.5 were selected as the screening threshold. Formation and inactivation of 17β-oestradiol resulted similar between groups. Inhibition of HSD17B1 activity was significantly higher in the non-pregnant group when only primary infertile women (n = 12) were considered (27.1%, n = 5 vs 16.2%, n = 7, P = 0.04). Gene expression analysis confirmed the presence of HSD17B1 (encoding HSD17B1), HSD17B2 (encoding HSD17B2) and 33 of 46 analysed steroid metabolising enzymes in the endometrium. In the primary infertile subgroup (n = 10) 12 DEGs were found including LINC02349 which has been linked to implantation. However, the exact relationship between steroid-metabolising enzyme activity, expression and implantation outcome requires further investigation in larger, well-defined patient groups.
Sex hormones are produced and broken down by enzymes that can be found in the endometrium (the inner lining of the womb). This enzyme activity might influence the chances of becoming pregnant. We compared (i) enzyme activity in the endometrium of 15 women who did and 15 women who did not become pregnant in their second in vitro fertilisation attempt, (ii) how enzyme activity can be blocked by an inhibitor, and (iii) differences in gene expression (the process by which instructions in our DNA are converted into a product). Enzyme activity was similar between groups. We found that in women who have never been pregnant in the past, inhibition of enzyme activity was higher and found differences in a gene that has been linked to the implantation of the embryo, but future studies should be performed in larger, well-defined patient groups to confirm these findings.
甾体激素可被子宫内膜类固醇代谢酶转化为生物活性代谢物,反之亦然。研究表明,这种代谢的改变可能会影响子宫内膜的容受性。本研究旨在确定在接受体外受精/卵胞浆内单精子注射(ICSI)的女性中,假设的胚胎接受子宫内膜和非接受子宫内膜之间 17β-雌二醇的形成和失活是否存在差异。在自然周期排卵后 5-8 天,即在新鲜胚胎移植(ET)的第二次 IVF/ICSI 周期之前,从 IVF/ICSI 患者中获得子宫内膜活检。将新鲜 ET 后获得临床妊娠的患者(n=15)的子宫内膜活检与新鲜 ET 后未妊娠的患者(n=15)的子宫内膜活检进行比较。通过高效液相色谱法测定 17β-雌二醇(氧化 17β-羟甾脱氢酶(HSDs))、雌酮(还原 HSD17B)和 HSD17B1 活性抑制的形成。使用 RNA 测序进行子宫内膜转录组分析,随后进行主成分分析和差异表达基因分析。选择错误发现率校正 P<0.05 和对数倍数变化>0.5 作为筛选阈值。结果显示,两组之间 17β-雌二醇的形成和失活结果相似。当仅考虑原发性不孕女性(n=12)时,非妊娠组的 HSD17B1 活性抑制(27.1%,n=5 与 16.2%,n=7,P=0.04)显著更高。基因表达分析证实了 HSD17B1(编码 HSD17B1)、HSD17B2(编码 HSD17B2)和 46 种分析类固醇代谢酶中的 33 种在子宫内膜中的存在。在原发性不孕亚组(n=10)中发现了 12 个差异表达基因,包括与着床相关的 LINC02349。然而,类固醇代谢酶活性、表达与着床结果之间的确切关系需要在更大、定义更明确的患者群体中进一步研究。
研究背景:甾体激素是由子宫内膜(子宫的内层)中的酶产生和分解的。这种酶的活性可能会影响怀孕的机会。
研究目的:我们比较了(i)15 名在第二次体外受精尝试中怀孕和 15 名未怀孕的女性的子宫内膜中酶的活性;(ii)酶活性被抑制剂阻断的情况;(iii)基因表达的差异(即 DNA 中的指令转化为产物的过程)。
研究方法:在自然周期排卵后 5-8 天,从接受 IVF/ICSI 的患者中获得子宫内膜活检。在新鲜胚胎移植(ET)的第二次 IVF/ICSI 周期前,将患者分为怀孕组和未怀孕组。使用高效液相色谱法测定 17β-雌二醇(氧化 17β-羟甾脱氢酶(HSDs))、雌酮(还原 HSD17B)和 HSD17B1 活性抑制的形成。使用 RNA 测序进行子宫内膜转录组分析,随后进行主成分分析和差异表达基因分析。
研究结果:两组之间 17β-雌二醇的形成和失活结果相似。当仅考虑原发性不孕女性(n=12)时,非妊娠组的 HSD17B1 活性抑制(27.1%,n=5 与 16.2%,n=7,P=0.04)显著更高。基因表达分析证实了 HSD17B1(编码 HSD17B1)、HSD17B2(编码 HSD17B2)和 46 种分析类固醇代谢酶中的 33 种在子宫内膜中的存在。在原发性不孕亚组(n=10)中发现了 12 个差异表达基因,包括与着床相关的 LINC02349。
研究结论:在原发性不孕女性中,HSD17B1 活性抑制可能更高,并且与胚胎着床相关的基因表达存在差异,但需要在更大、定义更明确的患者群体中进一步研究以证实这些发现。